Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 297(6): 101387, 2021 12.
Article in English | MEDLINE | ID: mdl-34758356

ABSTRACT

Juvenile hormone (JH) plays vital roles in insect reproduction, development, and in many aspects of physiology. JH primarily acts at the gene-regulatory level through interaction with an intracellular receptor (JH receptor [JHR]), a ligand-activated complex of transcription factors consisting of the JH-binding protein methoprene-tolerant (MET) and its partner taiman (TAI). Initial studies indicated significance of post-transcriptional phosphorylation, subunit assembly, and nucleocytoplasmic transport of JHR in JH signaling. However, our knowledge of JHR regulation at the protein level remains rudimentary, partly because of the difficulty of obtaining purified and functional JHR proteins. Here, we present a method for high-yield expression and purification of JHR complexes from two insect species, the beetle T. castaneum and the mosquito Aedes aegypti. Recombinant JHR subunits from each species were coexpressed in an insect cell line using a baculovirus system. MET-TAI complexes were purified through affinity chromatography and anion exchange columns to yield proteins capable of binding both the hormonal ligand (JH III) and DNA bearing cognate JH-response elements. We further examined the beetle JHR complex in greater detail. Biochemical analyses and MS confirmed that T. castaneum JHR was a 1:1 heterodimer consisting of MET and Taiman proteins, stabilized by the JHR agonist ligand methoprene. Phosphoproteomics uncovered multiple phosphorylation sites in the MET protein, some of which were induced by methoprene treatment. Finally, we report a functional bipartite nuclear localization signal, straddled by phosphorylated residues, within the disordered C-terminal region of MET. Our present characterization of the recombinant JHR is an initial step toward understanding JHR structure and function.


Subject(s)
Aedes/metabolism , Insect Proteins/metabolism , Protein Processing, Post-Translational , Receptors, Cell Surface/metabolism , Tribolium/metabolism , Aedes/genetics , Animals , Insect Proteins/genetics , Juvenile Hormones/metabolism , Phosphorylation , Receptors, Cell Surface/genetics , Sf9 Cells , Spodoptera , Tribolium/genetics
2.
Protein Expr Purif ; 100: 10-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24810910

ABSTRACT

The HIV-1 Gag precursor protein, Pr55(Gag), is a multi-domain polyprotein that drives HIV-1 assembly. The morphological features of HIV-1 suggested Pr55(Gag) assumes a variety of different conformations during virion assembly and maturation, yet structural determination of HIV-1 Pr55(Gag) has not been possible due to an inability to express and to isolate large amounts of full-length recombinant Pr55(Gag) for biophysical and biochemical analyses. This challenge is further complicated by HIV-1 Gag's natural propensity to multimerize for the formation of viral particle (with ∼2500 Gag molecules per virion), and this has led Pr55(Gag) to aggregate and be expressed as inclusion bodies in a number of in vitro protein expression systems. This study reported the production of a recombinant form of HIV-1 Pr55(Gag) using a bacterial heterologous expression system. Recombinant HIV-1 Pr55(Gag) was expressed with a C-terminal His×6 tag, and purified using a combination of immobilized metal affinity chromatography and size exclusion chromatography. This procedure resulted in the production of milligram quantities of high purity HIV-1 Pr55(Gag) that has a mobility that resembles a trimer in solution using size exclusion chromatography analysis. The high quantity and purity of the full length HIV Gag will be suitable for structural and functional studies to further understand the process of viral assembly, maturation and the development of inhibitors to interfere with the process.


Subject(s)
Escherichia coli/genetics , HIV Infections/virology , HIV-1/genetics , Protein Precursors/genetics , Protein Precursors/isolation & purification , Amino Acid Sequence , Base Sequence , Chromatography, Affinity/methods , Gene Expression , HIV-1/chemistry , Humans , Metals/chemistry , Molecular Sequence Data , Plasmids/genetics , Protein Precursors/chemistry , Protein Precursors/ultrastructure , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/ultrastructure , Solubility , Transformation, Bacterial
3.
J Biol Chem ; 288(1): 59-68, 2013 Jan 04.
Article in English | MEDLINE | ID: mdl-23166326

ABSTRACT

Insulin-like growth factor II (IGF-II) is a major embryonic growth factor belonging to the insulin-like growth factor family, which includes insulin and IGF-I. Its expression in humans is tightly controlled by maternal imprinting, a genetic restraint that is lost in many cancers, resulting in up-regulation of both mature IGF-II mRNA and protein expression. Additionally, increased expression of several longer isoforms of IGF-II, termed "pro" and "big" IGF-II, has been observed. To date, it is ambiguous as to what role these IGF-II isoforms have in initiating and sustaining tumorigenesis and whether they are bioavailable. We have expressed each individual IGF-II isoform in their proper O-glycosylated format and established that all bind to the IGF-I receptor and both insulin receptors A and B, resulting in their activation and subsequent stimulation of fibroblast proliferation. We also confirmed that all isoforms are able to be sequestered into binary complexes with several IGF-binding proteins (IGFBP-2, IGFBP-3, and IGFBP-5). In contrast to this, ternary complex formation with IGFBP-3 or IGFBP-5 and the auxillary protein, acid labile subunit, was severely diminished. Furthermore, big-IGF-II isoforms bound much more weakly to purified ectodomain of the natural IGF-II scavenging receptor, IGF-IIR. IGF-II isoforms thus possess unique biological properties that may enable them to escape normal sequestration avenues and remain bioavailable in vivo to sustain oncogenic signaling.


Subject(s)
Insulin-Like Growth Factor II/chemistry , Neoplasms/metabolism , Animals , Cell Proliferation , Fibroblasts/cytology , Gene Expression Regulation, Neoplastic , Glycosylation , HEK293 Cells , Humans , Insulin-Like Growth Factor Binding Proteins/chemistry , Insulin-Like Growth Factor I/chemistry , Mass Spectrometry/methods , Mice , Protein Binding , Protein Isoforms , Protein Structure, Tertiary , Receptor Protein-Tyrosine Kinases/chemistry , Signal Transduction
4.
PLoS One ; 7(6): e37779, 2012.
Article in English | MEDLINE | ID: mdl-22701579

ABSTRACT

In 1988 the preceding journal of Nature Biotechnology, Bio/Technology, reported a work by Hopp and co-workers about a new tag system for the identification and purification of recombinant proteins: the FLAG-tag. Beside the extensively used hexa-his tag system the FLAG-tag has gained broad popularity due to its small size, its high solubility, the presence of an internal Enterokinase cleavage site, and the commercial availability of high-affinity anti-FLAG antibodies. Surprisingly, considering the heavy use of FLAG in numerous laboratories world-wide, we identified in insect cells a post-translational modification (PTM) that abolishes the FLAG-anti-FLAG interaction rendering this tag system ineffectual for secreted proteins. The present publication shows that the tyrosine that is part of the crucial FLAG epitope DYK is highly susceptible to sulfation, a PTM catalysed by the enzyme family of Tyrosylprotein-Sulfo-transferases (TPSTs). We showed that this modification can result in less than 20% of secreted FLAG-tagged protein being accessible for purification questioning the universal applicability of this established tag system.


Subject(s)
Epitopes/genetics , Neuraminidase/metabolism , Peptides/genetics , Peptides/metabolism , Recombinant Proteins/metabolism , Sulfotransferases/metabolism , Animals , Antibodies/immunology , Blotting, Western , Cell Line , Chromatography, Affinity , Chromatography, Gel , Epitopes/immunology , Epitopes/metabolism , HEK293 Cells , Humans , Insecta , Mass Spectrometry , Neuraminidase/isolation & purification , Oligopeptides , Peptides/immunology , Peptides/isolation & purification
5.
Mol Cancer Ther ; 9(6): 1809-19, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20515953

ABSTRACT

Elevated expression of insulin-like growth factor-II (IGF-II) is frequently observed in a variety of human malignancies, including breast, colon, and liver cancer. As IGF-II can deliver a mitogenic signal through both IGF-IR and an alternately spliced form of the insulin receptor (IR-A), neutralizing the biological activity of this growth factor directly is a potential alternative option to IGF-IR-directed agents. Using a Fab-displaying phage library and a biotinylated precursor form of IGF-II (1-104 amino acids) as a target, we isolated Fabs specific for the E-domain COOH-terminal extension form of IGF-II and for mature IGF-II. One of these Fabs that bound to both forms of IGF-II was reformatted into a full-length IgG, expressed, purified, and subjected to further analysis. This antibody (DX-2647) displayed a very high affinity for IGF-II/IGF-IIE (K(D) value of 49 and 10 pmol/L, respectively) compared with IGF-I (approximately 10 nmol/L) and blocked binding of IGF-II to IGF-IR, IR-A, a panel of insulin-like growth factor-binding proteins, and the mannose-6-phosphate receptor. A crystal complex of the parental Fab of DX-2647 bound to IGF-II was resolved to 2.2 A. DX-2647 inhibited IGF-II and, to a lesser extent, IGF-I-induced receptor tyrosine phosphorylation, cellular proliferation, and both anchorage-dependent and anchorage-independent colony formation in various cell lines. In addition, DX-2647 slowed tumor progression in the Hep3B xenograft model, causing decreased tumoral CD31 staining as well as reduced IGF-IIE and IGF-IR phosphorylation levels. Therefore, DX-2647 offers an alternative approach to targeting IGF-IR, blocking IGF-II signaling through both IGF-IR and IR-A.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/pathology , Insulin-Like Growth Factor II/immunology , Liver Neoplasms/drug therapy , Liver Neoplasms/pathology , Animals , Antibodies, Monoclonal/pharmacology , Cell Adhesion/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Disease Progression , Humans , Immunohistochemistry , Mice , Signal Transduction/drug effects , Tumor Stem Cell Assay , Xenograft Model Antitumor Assays
6.
Proteins ; 71(1): 426-39, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17957771

ABSTRACT

The human insulin receptor (IR) homodimer is heavily glycosylated and contains a total of 19 predicted N-linked glycosylation sites in each monomer. The recent crystal structure of the IR ectodomain shows electron density consistent with N-linked glycosylation at the majority of sites present in the construct. Here, we describe a refined structure of the IR ectodomain that incorporates all of the N-linked glycans and reveals the extent to which the attached glycans mask the surface of the IR dimer from interaction with antibodies or other potential therapeutic binding proteins. The usefulness of Fab complexation in the crystallization of heavily glycosylated proteins is also discussed. The compositions of the glycans on IR expressed in CHO-K1 cells and the glycosylation deficient Lec8 cell line were determined by protease digestion, glycopeptide purification, amino acid sequence analysis, and mass spectrometry. Collectively the data reveal: multiple species of complex glycan at residues 25, 255, 295, 418, 606, 624, 742, 755, and 893 (IR-B numbering); multiple species of high-mannose glycan at residues 111 and 514; a single species of complex glycan at residue 671; and a single species of high-mannose glycan at residue 215. Residue 16 exhibited a mixture of complex, hybrid, and high-mannose glycan species. Of the remaining five predicted N-linked sites, those at residues 397 and 906 were confirmed by amino acid sequencing to be glycosylated, while that at residue 78 and the atypical (NKC) site at residue 282 were not glycosylated. The peptide containing the final site at residue 337 was not recovered but is seen to be glycosylated in the electron density maps of the IR ectodomain. The model of the fully glycosylated IR reveals that the sites carrying high-mannose glycans lie at positions of relatively low steric accessibility.


Subject(s)
Antigens, CD/chemistry , Polysaccharides/analysis , Receptor, Insulin/chemistry , Crystallization/methods , Crystallography, X-Ray , Glycosylation , Humans , Mass Spectrometry
7.
Proteins ; 66(2): 261-5, 2007 Feb 01.
Article in English | MEDLINE | ID: mdl-17078079

ABSTRACT

O-linked glycosylation is a post-translational and post-folding event involving exposed S/T residues at beta-turns or in regions with extended conformation. O-linked sites are difficult to predict from sequence analyses compared to N-linked sites. Here we compare the results of chemical analyses of isolated glycopeptides with the prediction using the neural network prediction method NetOGlyc3.1, a procedure that has been reported to correctly predict 76% of O-glycosylated residues in proteins. Using the heavily glycosylated human insulin receptor as the test protein six sites of mucin-type O-glycosylation were found at residues T744, T749, S757, S758, T759, and T763 compared to the three sites (T759 and T763- correctly, T756- incorrectly) predicted by the neural network method. These six sites occur in a 20 residue segment that begins nine residues downstream from the start of the insulin receptor beta-chain. This region which also includes N-linked glycosylation sites at N742 and N755, is predicted to lack secondary structure and is followed by residues 765-770, the known linear epitope for the monoclonal antibody 18-44.


Subject(s)
Polysaccharides/analysis , Protein Processing, Post-Translational , Receptor, Insulin/chemistry , Acetylgalactosamine/analysis , Animals , CHO Cells , Cell Line , Chromatography, High Pressure Liquid , Cricetinae , Cricetulus , Epitopes/immunology , Glycopeptides/analysis , Glycosylation , Humans , Monosaccharide Transport Proteins/deficiency , Monosaccharide Transport Proteins/genetics , Monosaccharide Transport Proteins/metabolism , Neural Networks, Computer , Protein Conformation , Receptor, IGF Type 1/analysis , Receptor, Insulin/genetics , Receptor, Insulin/immunology , Recombinant Fusion Proteins/analysis , Serine/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Threonine/chemistry
8.
Nature ; 443(7108): 218-21, 2006 Sep 14.
Article in English | MEDLINE | ID: mdl-16957736

ABSTRACT

The insulin receptor is a phylogenetically ancient tyrosine kinase receptor found in organisms as primitive as cnidarians and insects. In higher organisms it is essential for glucose homeostasis, whereas the closely related insulin-like growth factor receptor (IGF-1R) is involved in normal growth and development. The insulin receptor is expressed in two isoforms, IR-A and IR-B; the former also functions as a high-affinity receptor for IGF-II and is implicated, along with IGF-1R, in malignant transformation. Here we present the crystal structure at 3.8 A resolution of the IR-A ectodomain dimer, complexed with four Fabs from the monoclonal antibodies 83-7 and 83-14 (ref. 4), grown in the presence of a fragment of an insulin mimetic peptide. The structure reveals the domain arrangement in the disulphide-linked ectodomain dimer, showing that the insulin receptor adopts a folded-over conformation that places the ligand-binding regions in juxtaposition. This arrangement is very different from previous models. It shows that the two L1 domains are on opposite sides of the dimer, too far apart to allow insulin to bind both L1 domains simultaneously as previously proposed. Instead, the structure implicates the carboxy-terminal surface of the first fibronectin type III domain as the second binding site involved in high-affinity binding.


Subject(s)
Protein Folding , Receptor, Insulin/chemistry , Receptor, Insulin/metabolism , Crystallography, X-Ray , Dimerization , Immunoglobulin Fab Fragments/immunology , Microscopy, Electron , Models, Molecular , Protein Structure, Quaternary , Protein Structure, Tertiary , Receptor, Insulin/immunology , Receptor, Insulin/ultrastructure
9.
Acta Crystallogr D Biol Crystallogr ; 59(Pt 3): 558-60, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12595725

ABSTRACT

Human sorbitol dehydrogenase (SDH) was expressed in Escherichia coli BL21 cells and purified using ammonium sulfate precipitation and anion-exchange and dye-affinity chromatography. Purified SDH was crystallized from polyethylene glycol solutions using the hanging-drop vapour-diffusion method. X-ray data were collected to 2.75 A resolution. The crystals belong to the monoclinic C2 space group, with unit-cell parameters a = 145.9, b = 52.3, c = 169.0 A, beta = 101.8 degrees. This is the first crystallization report of human sorbitol dehydrogenase.


Subject(s)
L-Iditol 2-Dehydrogenase/chemistry , Crystallography, X-Ray , DNA, Complementary/biosynthesis , Electrophoresis, Polyacrylamide Gel , Humans , L-Iditol 2-Dehydrogenase/biosynthesis , L-Iditol 2-Dehydrogenase/isolation & purification , Liver/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...